Cite
DIPG-58. HISTONE H3 WILD-TYPE DIPG/DMG OVEREXPRESSING EZHIP EXTEND THE SPECTRUM OF DIFFUSE MIDLINE GLIOMAS WITH PRC2 INHIBITION BEYOND H3-K27M MUTATION
MLA
David T.W. Jones, et al. “Dipg-58. Histone H3 Wild-Type Dipg/Dmg Overexpressing Ezhip Extend the Spectrum of Diffuse Midline Gliomas with Prc2 Inhibition beyond H3-K27m Mutation.” Neuro-Oncology, vol. 22, Dec. 2020, p. iii298. EBSCOhost, https://doi.org/10.1093/neuonc/noaa222.103.
APA
David T.W. Jones, David Castel, Pascale Varlet, Arnault Tauziède-Espariat, Chris Jones, Stefan M. Pfister, Alan Mackay, Samia Ghermaoui, Nathalie Boddaert, Christof M. Kramm, Emmanuèle Lechapt, Stéphanie Puget, Thomas Blauwblomme, Marie-Anne Debily, Kevin Beccaria, Thomas Kergrohen, & Jacques Grill. (2020). Dipg-58. Histone H3 Wild-Type Dipg/Dmg Overexpressing Ezhip Extend the Spectrum of Diffuse Midline Gliomas with Prc2 Inhibition beyond H3-K27m Mutation. Neuro-Oncology, 22, iii298. https://doi.org/10.1093/neuonc/noaa222.103
Chicago
David T.W. Jones, David Castel, Pascale Varlet, Arnault Tauziède-Espariat, Chris Jones, Stefan M. Pfister, Alan Mackay, et al. 2020. “Dipg-58. Histone H3 Wild-Type Dipg/Dmg Overexpressing Ezhip Extend the Spectrum of Diffuse Midline Gliomas with Prc2 Inhibition beyond H3-K27m Mutation.” Neuro-Oncology 22 (December): iii298. doi:10.1093/neuonc/noaa222.103.